Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers

September 28, 2022 updated by: Le Hong Duc, Pham Ngoc Thach University of Medicine

Continuing Medical Education (CME) Intervention to Improve Knowledge About Viral Hepatitis B-C: A Randomized Controlled Trial Pilot at Primary-level Hospitals in Ho Chi Minh City

The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Vietnam
    • Ho Chi Minh City
      • Tháng 07, Ho Chi Minh City, Vietnam, 700000
        • Lê Hồng Đức

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

24 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Currently working at Outpatient department, Primary-level hospitals
  • Having Practicing Certificate
  • Not attending any long-term education
  • Accepting ICF

Exclusion Criteria:

  • Not attending the full number of lessons
  • Not answering the questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Received CME
Behavioral: Continuing medical education
Education section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV
No Intervention: Not received CME

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months
Time Frame: 6 months
Participants have exams pre- and post-6-months-course, which is multiple choice questions. The test score is average number of correct answers. The pre- and post-6-months exams use the same structure and questions. A change in test score is the difference between test score of the post-6-months-exam and test score of the pre-course-exam.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pham Ngoc Thach University of Medicine

Investigators

  • Principal Investigator: Lê H Đức, Medicine, Pham Ngoc Thach University of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 10, 2022

Primary Completion (Anticipated)

February 10, 2023

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

December 9, 2021

First Submitted That Met QC Criteria

January 11, 2022

First Posted (Actual)

January 26, 2022

Study Record Updates

Last Update Posted (Actual)

September 30, 2022

Last Update Submitted That Met QC Criteria

September 28, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 511/TĐHYKPNT-HĐĐĐ

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Viral Hepatitis

Clinical Trials on Continuing medical education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe